Peter Croucher
Garvan Institute of Medical Research, NSW, Australia
- This delegate is presenting an abstract at this event.

Peter undertook his training at the University College Cardiff and the University of Wales College of Medicine. He did post-doctoral training in the Department of Medicine and LMB in Cambridge and Clinical Biochemistry in Sheffield where he became a Leukeamia Research Fund Bennett Senior Research Fellow. In 2001 he moved to the Institute of Musculoskeletal Sciences at Oxford University. In 2009 Peter was appointed the inaugural joint Direct of the Mellanby Center for Bone Research and the Head of the Department of Human Metabolism, at the University of Sheffield.
Peter joined the Garvan Institute in December 2011 as Head of the Osteoporosis and Bone Program and now leads the Division of Bone Biology. Peter’s research interests are in understanding the cellular and molecular mechanisms responsible for physiological and pathological regulation of the skeleton. He has a particular interest in tumors that grow in bone such as multiple myeloma, or those that metastasise to bone, including prostate and breast cancer.
Presentations this author is a contributor to:
Tram2 is a novel genetic determinant of bone mass and strength (#28)
4:00 PM
Victoria D Leitch
Outstanding abstracts
Osteocytes express a unique transcriptome that underpins skeletal homeostasis (#59)
4:48 PM
Scott E Youlten
New Investigator session
The osteocyte transcriptome shows major temporal changes during maturation and sexual dimorphism in adulthood (#125)
5:00 PM
Scott E Youlten
Welcome Reception & ANZBMS Plenary Posters
Anti-sclerostin antibody treatment prevents myeloma bone disease and increases bone strength (#30)
4:40 PM
Michelle M McDonald
Outstanding abstracts
Novel bone anabolic genes in high bone mass families (#86)
4:30 PM
John A Eisman
Advances in bone biology (II) and Late-breaking abstracts